In Vitro Chromosomal Aberration Assay
The chromosomal aberration test is designed to evaluate the potential of a test compound to induce structural chromosomal abnormalities such as breaks and exchanges.
North American Genetic Toxicology Workshop
Learn how to successfully execute Genetic toxicology testing, satisfying regulatory criteria and smoothing your path to market.
Chromosomal Aberration Test Procedure
- The chromosomal aberration test can be performed in primary human peripheral blood lymphocytes (HPBL) or established cell lines, such as Chinese hamster ovary (CHO) cells.
- Cultures are incubated with several concentrations of the test compound for 3 to 4 hours in the presence and absence of metabolic activation (S9) and for 21 hours in the absence of S9.
- A positive outcome is characterized by a statistically significant, dose-dependent increase in aberrant cells that exceeds historical negative control limits.
Metaphase spread of human lymphocyte showing multiple chromosome aberration
When to Perform the Chromosomal Aberration Test
- Screening
- IND-enabling studies
- As part of the ICH S2(R1) standard battery
- REACH requirement
- As part of Annex VIII testing